Indications and Usage

Tirzero® Slim is indicated for use in adults aged 18 years and older for the treatment of:

Type 2 Diabetes Mellitus (T2D)
Tirzero® Slim is indicated for the treatment of adults with insufficiently controlled T2D as an adjunct to diet and physical activity:

• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications;
• in addition to other medicinal products for the treatment of T2D.

Weight Management
Tirzero® Slim is indicated as an adjunct therapy to a reduced-calorie diet and increased physical activity for weight loss and weight management in adults over 18 years of age with an initial Body Mass Index (BMI) of:

• 30 kg/m² or greater (obesity);
• or from 27 kg/m² to less than 30 kg/m² (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, obstructive sleep apnea [OSA], cardiovascular disease, prediabetes, or T2D).

Regulatory Status: Rx only.

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the Tirzero® Slim (tirzepatide) leaflet, please visit this website: https://grls.rosminzdrav.ru/Default.aspx